Efficacy and Safety of DKF-313 in Patients With Benign Prostatic Hyperplasia
Condition: Benign Prostatic Hyperplasia Interventions: Drug: DKF-313; Drug: Dutasteride; Drug: Tadalafil; Drug: DKF-313 placebo; Drug: Dutasteride placebo; Drug: Tadalafil placebo Sponsor: Dongkook Pharmaceutical Co., Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials